2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Breast Neoplasms
32
Pain, Postoperative
18
Neoplasms
16
Parkinson Disease 4, Autosomal Dominant Lewy Body
13
Lung Neoplasms
12
Brain Neoplasms
12
Prostatic Neoplasms
9
Ovarian Neoplasms
9
Colonic Neoplasms
8
Carcinoma, Hepatocellular
8
Stomach Neoplasms
7
Depression
7
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Pain
6
Head and Neck Neoplasms
6
Thyroid Neoplasms
5
Pancreatic Neoplasms
5
Multiple Myeloma
5
Leiomyoma
5
Agnosia
5
Neoplasm Metastasis
4
Lymphoma
4
Fatigue
4
Delirium
4
Anxiety Disorders
4
Urinary Bladder Neoplasms
3
Thromboembolism
3
Supratentorial Neoplasms
3
Stomatitis
3
Interventions
ferric carboxymaltose
6
iron isomaltoside 1000
4
ferric derisomaltose
2
Iron-Dextran Complex
2
ferroglycine sulfate
1
Tomography, X-Ray Computed
1
Surveys and Questionnaires
1
Sodium Chloride
1
Saline Solution
1
Radiotherapy, Intensity-Modulated
1
Niferex
1
Iron
1
Gastroscopy
1
Ferric Oxide, Saccharated
1
Endoscopy
1
Control Groups
1
Colonoscopy
1
Colonography, Computed Tomographic
1
Betaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anemia, Iron-Deficiency
×
Saline Solution
×
Clear all
NCT05467319
2022-07-20
FORGE
Alberta Health Services, Calgary
Phase 3
Unknown
82 enrolled